{"count": 1, "results": [{"_id": "36746021", "pmid": 36746021, "title": "STAT3 as a therapeutic target in the metformin-related treatment.", "journal": "Int Immunopharmacol", "authors": ["Zhang W", "Li D", "Li B", "Chu X", "Kong B"], "date": "2023-03-01T00:00:00Z", "doi": "10.1016/j.intimp.2023.109770", "meta_date_publication": "2023 Mar", "meta_volume": "116", "meta_issue": "", "meta_pages": "109770", "score": 50257.01, "text_hl": "Here, we reviewed in detail that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibits the progression of various diseases like @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumors@@@, @DISEASE_Autoimmune_Diseases @DISEASE_MESH:D001327 @@@autoimmune diseases@@@ and @<m>DISEASE_Immunoglobulin_G4_Related_Disease</m> @DISEASE_MESH:D000077733 @@@hormone-related diseases@@@ by regulating multiple signaling pathways such as JAK/@GENE_STAT3 @GENE_6774 @@@STAT3@@@ and @GENE_MTOR @GENE_2475 @@@mTOR@@@/@GENE_STAT3 @GENE_6774 @@@STAT3@@@ signaling centered on @GENE_STAT3 @GENE_6774 @@@STAT3@@@. ", "citations": {"NLM": "Zhang W, Li D, Li B, Chu X, Kong B. STAT3 as a therapeutic target in the metformin-related treatment. Int Immunopharmacol. 2023 Mar;116():109770. PMID: 36746021", "BibTeX": "@article{36746021, title={STAT3 as a therapeutic target in the metformin-related treatment.}, author={Zhang W and Li D and Li B and Chu X and Kong B}, journal={Int Immunopharmacol}, volume={116}, pages={109770}}"}}]}